FDA moves to real-time clinical trial patient monitoring, faster drug review
The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.
Apr 29, 2026
0
3
Clinical pharmacology news
One molecule, two effects: A new drug concept to treat obesity and type 2 diabetes
A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signaling pathway as a "door ...
Apr 29, 2026
0
11
Reclassification of marijuana opens doors for much‑needed medical research into the benefits and risks of the drug
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive ...
Apr 29, 2026
0
5
Choosing safer diabetes medications for older adults
Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often underrepresented in the clinical trials that guide treatment decisions. A new study ...
Apr 29, 2026
0
7
New HIV vaccine design trains immune system to hit shared viral target across variants
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly ...
Apr 29, 2026
0
12
Americans support cannabis rescheduling, study finds
Most people strongly support the federal government's reclassification of cannabis, according to a new study that used AI to analyze more than 40,000 comments in the public record. The findings by researchers at Johns Hopkins ...
Apr 29, 2026
0
5
Professor urges better prevention and care of liver disease to reduce burden
A University of Houston College of Pharmacy professor has published two studies offering a comprehensive look at chronic liver disease in the era of modern antiviral therapies. One study is the first analysis of its economic ...
Apr 29, 2026
0
5
Rethinking mRNA vaccines: Liver targeting can suppress immunity, while muscle boosts it
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help determine vaccine effectiveness.
Apr 29, 2026
0
25
Bariatric surgery is associated with greater long-term heart risk reduction than weight-loss medications
A Mayo Clinic study has found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term ...
Apr 28, 2026
0
4
Digital twin can reveal alcohol consumption in crime cases
Using a so-called digital twin, it is possible to predict with greater precision than at present how much alcohol a person has consumed and at what time. The study was conducted by researchers at Linköping University and ...
Apr 28, 2026
0
5
